S&P 500   4,337.44 (+0.40%)
DOW   34,006.88 (+0.13%)
QQQ   359.61 (+0.47%)
AAPL   176.08 (+0.74%)
MSFT   317.54 (+0.17%)
META   300.83 (+0.59%)
GOOGL   131.11 (+0.66%)
AMZN   131.27 (+1.67%)
TSLA   246.99 (+0.86%)
NVDA   422.22 (+1.47%)
NIO   8.34 (-2.23%)
BABA   87.20 (-1.25%)
AMD   97.38 (+1.23%)
T   15.06 (-0.40%)
F   12.59 (+1.29%)
MU   68.58 (-0.44%)
CGC   0.94 (+11.86%)
GE   111.70 (+0.40%)
DIS   81.01 (-0.30%)
AMC   8.15 (+6.82%)
PFE   32.98 (+0.89%)
PYPL   58.86 (+1.69%)
NFLX   384.80 (+1.31%)
S&P 500   4,337.44 (+0.40%)
DOW   34,006.88 (+0.13%)
QQQ   359.61 (+0.47%)
AAPL   176.08 (+0.74%)
MSFT   317.54 (+0.17%)
META   300.83 (+0.59%)
GOOGL   131.11 (+0.66%)
AMZN   131.27 (+1.67%)
TSLA   246.99 (+0.86%)
NVDA   422.22 (+1.47%)
NIO   8.34 (-2.23%)
BABA   87.20 (-1.25%)
AMD   97.38 (+1.23%)
T   15.06 (-0.40%)
F   12.59 (+1.29%)
MU   68.58 (-0.44%)
CGC   0.94 (+11.86%)
GE   111.70 (+0.40%)
DIS   81.01 (-0.30%)
AMC   8.15 (+6.82%)
PFE   32.98 (+0.89%)
PYPL   58.86 (+1.69%)
NFLX   384.80 (+1.31%)
S&P 500   4,337.44 (+0.40%)
DOW   34,006.88 (+0.13%)
QQQ   359.61 (+0.47%)
AAPL   176.08 (+0.74%)
MSFT   317.54 (+0.17%)
META   300.83 (+0.59%)
GOOGL   131.11 (+0.66%)
AMZN   131.27 (+1.67%)
TSLA   246.99 (+0.86%)
NVDA   422.22 (+1.47%)
NIO   8.34 (-2.23%)
BABA   87.20 (-1.25%)
AMD   97.38 (+1.23%)
T   15.06 (-0.40%)
F   12.59 (+1.29%)
MU   68.58 (-0.44%)
CGC   0.94 (+11.86%)
GE   111.70 (+0.40%)
DIS   81.01 (-0.30%)
AMC   8.15 (+6.82%)
PFE   32.98 (+0.89%)
PYPL   58.86 (+1.69%)
NFLX   384.80 (+1.31%)
S&P 500   4,337.44 (+0.40%)
DOW   34,006.88 (+0.13%)
QQQ   359.61 (+0.47%)
AAPL   176.08 (+0.74%)
MSFT   317.54 (+0.17%)
META   300.83 (+0.59%)
GOOGL   131.11 (+0.66%)
AMZN   131.27 (+1.67%)
TSLA   246.99 (+0.86%)
NVDA   422.22 (+1.47%)
NIO   8.34 (-2.23%)
BABA   87.20 (-1.25%)
AMD   97.38 (+1.23%)
T   15.06 (-0.40%)
F   12.59 (+1.29%)
MU   68.58 (-0.44%)
CGC   0.94 (+11.86%)
GE   111.70 (+0.40%)
DIS   81.01 (-0.30%)
AMC   8.15 (+6.82%)
PFE   32.98 (+0.89%)
PYPL   58.86 (+1.69%)
NFLX   384.80 (+1.31%)
NASDAQ:BCAB

BioAtla (BCAB) Insider Trading & Ownership

$1.72
-0.07 (-3.91%)
(As of 09/25/2023 ET)
Compare
Today's Range
$1.67
▼
$1.82
50-Day Range
$1.79
▼
$3.07
52-Week Range
$1.67
▼
$11.73
Volume
294,936 shs
Average Volume
522,017 shs
Market Capitalization
$82.22 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$15.33
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media

BioAtla (NASDAQ:BCAB) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
8.38%
Number Of
Insiders Buying
(Last 12 Months)
3
Amount Of
Insider Buying
(Last 12 Months)
$201,217.00
Number Of
Insiders Selling
(Last 12 Months)
0
Get BCAB Insider Trade Alerts

Want to know when executives and insiders are buying or selling BioAtla stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

BCAB Insider Buying and Selling by Quarter


BioAtla Insider Trades History

Export to Excel
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/8/2023Sylvia McbrinnDirectorBuy2,000$2.54$5,080.0011,125  
3/29/2023Jay M Phd ShortCEOBuy40,800$2.47$100,776.001,412,387  
3/28/2023Christian VasquezInsiderBuy20,000$2.40$48,000.00102,709  
12/19/2022Sylvia McbrinnDirectorBuy3,700$8.33$30,821.009,125  
11/22/2022Sylvia McbrinnDirectorBuy2,000$8.27$16,540.005,425  
(Data available from 1/1/2013 forward)












BCAB Insider Trading Activity - Frequently Asked Questions

Who is on BioAtla's Insider Roster?

The list of insiders at BioAtla includes Christian Vasquez, Cormorant Asset Management, Lp, Eric Sievers, Guy Levy, Jay M Phd Short, Lawrence Steinman, Richard A Waldron, Scott Andrew Smith, and Sylvia Mcbrinn. Learn more on insiders at BCAB.

What percentage of BioAtla stock is owned by insiders?

8.38% of BioAtla stock is owned by insiders. Learn more on BCAB's insider holdings.

Which BioAtla insiders have been buying company stock?

The following insiders have purchased BCAB shares in the last 24 months: Christian Vasquez ($120,722.08), Jay M Phd Short ($388,498.78), and Sylvia Mcbrinn ($70,141.00).

How much insider buying is happening at BioAtla?

Insiders have purchased a total of 150,084 BCAB shares in the last 24 months for a total of $579,361.86 bought.

Which BioAtla insiders have been selling company stock?

The following insiders have sold BCAB shares in the last 24 months: Christian Vasquez ($75,408.25), Eric Sievers ($17,990.88), Jay M Phd Short ($1,763,347.17), Lawrence Steinman ($13,500.00), Richard A Waldron ($469,768.66), and Scott Andrew Smith ($137,222.19).

How much insider selling is happening at BioAtla?

Insiders have sold a total of 100,914 BioAtla shares in the last 24 months for a total of $2,477,237.15 sold.


More Insider Trading Tools from MarketBeat

Related Companies:
Insider Tracking Tools:
Insider Trading By Country:
Latest Articles:
This page (NASDAQ:BCAB) was last updated on 9/25/2023 by MarketBeat.com Staff

My Account -